Katharina Meier

1.1k total citations
45 papers, 619 citations indexed

About

Katharina Meier is a scholar working on Epidemiology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Katharina Meier has authored 45 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 14 papers in Pathology and Forensic Medicine and 10 papers in Dermatology. Recurrent topics in Katharina Meier's work include Autoimmune Bullous Skin Diseases (12 papers), Oral Health Pathology and Treatment (7 papers) and Urticaria and Related Conditions (6 papers). Katharina Meier is often cited by papers focused on Autoimmune Bullous Skin Diseases (12 papers), Oral Health Pathology and Treatment (7 papers) and Urticaria and Related Conditions (6 papers). Katharina Meier collaborates with scholars based in Germany, United States and Italy. Katharina Meier's co-authors include Kamran Ghoreschi, Farzan Solimani, Julia Holstein, Stephan Forchhammer, Iris Schäfer, Amir S. Yazdi, Franziska Eberle, Franz J. Hilke, Stefan K. Drexler and Jens Waschke and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Scientific Reports.

In The Last Decade

Katharina Meier

34 papers receiving 609 citations

Peers

Katharina Meier

DERMA

PFM

RHEUM

IMMUN

EPIDE

Carlo Alberto Maronese Italy

Elisa Vega‐Memije Mexico

Farzan Solimani Germany

Kemal Özyurt Türkiye

Hayriye Sarıcaoğlu Türkiye

Qasem A. Alsaleh Kuwait

Maryam Nasimi Iran

Nessa Aghazadeh Iran

Antonio Zambrano Spain

Lynne Morrison United States

Carlo Alberto Maronese Italy

Katharina Meier

316 ×1.4

DERMA

155 ×0.7

PFM

120 ×0.8

RHEUM

142 ×1.0

IMMUN

205 ×1.6

EPIDE

Citations per year, relative to Katharina Meier Katharina Meier (= 1×) peers Carlo Alberto Maronese

Countries citing papers authored by Katharina Meier

Since Specialization

Citations

This map shows the geographic impact of Katharina Meier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharina Meier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharina Meier more than expected).

Fields of papers citing papers by Katharina Meier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharina Meier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharina Meier. The network helps show where Katharina Meier may publish in the future.

Co-authorship network of co-authors of Katharina Meier

This figure shows the co-authorship network connecting the top 25 collaborators of Katharina Meier. A scholar is included among the top collaborators of Katharina Meier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharina Meier. Katharina Meier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arnold, L, Friedegund Meier, Katharina Meier, et al.. (2025). Infliximab is a safe and effective treatment in steroid-refractory immune-related hepatitis. Journal for ImmunoTherapy of Cancer. 13(9). e013038–e013038.

Spitzer, Carsten, Ines Buchholz, Katharina Meier, et al.. (2025). Determinants of Quality of Life in Patients with Atopic Dermatitis and Psoriasis: A Multivariate Approach. Acta Dermato Venereologica. 105. adv42794–adv42794.

Spitzer, Carsten, Katharina Meier, Georgios Kokolakis, et al.. (2025). Facets of shame and their impact on quality of life in patients with atopic dermatitis and psoriasis. Scientific Reports. 15(1). 13753–13753.

Meier, Katharina, et al.. (2024). TYK2 inhibition with deucravacitinib ameliorates erosive oral lichen planus. Experimental Dermatology. 33(4). e15080–e15080. 9 indexed citations

Meier, Katharina, et al.. (2024). Characterisation of RSV infections in children without chronic diseases aged 0–36 months during the post-COVID-19 winter season 2022/2023. Frontiers in Pediatrics. 12. 1342399–1342399. 4 indexed citations

Didona, Dario, Katharina Meier, Roberto Maglie, et al.. (2024). Pathogenic relevance of antibodies against desmoglein 3 in patients with oral lichen planus. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 22(10). 1392–1399. 3 indexed citations

Hilke, Franz J., et al.. (2023). Interleukin‐21 in autoimmune and inflammatory skin diseases. European Journal of Immunology. 53(4). e2250075–e2250075. 30 indexed citations

Meier, Katharina, et al.. (2023). Diagnostik des okulären Schleimhautpemphigoids. Die Ophthalmologie. 120(5). 484–495. 1 indexed citations

Meier, Katharina, et al.. (2023). Blastische plasmazytoide dendritische Zellneoplasie (BPDCN). Die Dermatologie. 74(10). 787–792.

10.

Proft, Fabian, Theresa Hunter, Gustavo Luna, et al.. (2022). Early identification of axial psoriatic arthritis among patients with psoriasis: a prospective multicentre study. Annals of the Rheumatic Diseases. 81(11). 1534–1540. 12 indexed citations

11.

Kinberger, Maria, et al.. (2022). Granulomatöse Dermatosen. Zeitschrift für Rheumatologie. 81(7). 577–586.

12.

Schmitt, Thomas, Katharina Meier, Kamran Ghoreschi, et al.. (2022). Dsg1 and Dsg3 Composition of Desmosomes Across Human Epidermis and Alterations in Pemphigus Vulgaris Patient Skin. Frontiers in Immunology. 13. 884241–884241. 10 indexed citations

13.

Ghoreschi, Kamran, et al.. (2022). Lichen planus mucosae – eine diagnostische und therapeutische Herausforderung. Die Dermatologie. 73(9). 670–681.

14.

Solimani, Farzan, Katharina Meier, Christine L. Zimmer, & Takashi Hashimoto. (2021). Immune serological diagnosis of pemphigus. Italian Journal of Dermatology and Venereology. 156(2). 151–160. 6 indexed citations

15.

Meier, Katharina, et al.. (2021). Laugier-Hunziker-Syndrom. Der Hautarzt. 73(4). 298–302.

16.

Meier, Katharina, Julia Holstein, Farzan Solimani, Jens Waschke, & Kamran Ghoreschi. (2020). Case Report: Apremilast for Therapy-Resistant Pemphigus Vulgaris. Frontiers in Immunology. 11. 588315–588315. 17 indexed citations

17.

Solimani, Farzan, Katharina Meier, & Kamran Ghoreschi. (2019). Emerging Topical and Systemic JAK Inhibitors in Dermatology. Frontiers in Immunology. 10. 2847–2847. 207 indexed citations

18.

Ciana, Annarita, Katharina Meier, Nicole Schneider‐Daum, et al.. (2010). A dynamic ratio of the α⁺ and α⁻ isoforms of the tight junction protein ZO‐1 is characteristic of Caco‐2 cells and correlates with their degree of differentiation. Cell Biology International. 34(6). 669–678. 8 indexed citations

19.

Meier, Katharina, Claus‐Michael Lehr, & Nicole Schneider‐Daum. (2008). Differentiation potential of human pancreatic stem cells for epithelial- and endothelial-like cell types. Annals of Anatomy - Anatomischer Anzeiger. 191(1). 70–82. 3 indexed citations

20.

Simonsson, Bengt, Thomas H. Tötterman, Peter Hokland, et al.. (2000). Roquinimex (Linomide) vs placebo in AML after autologous bone marrow transplantation. Bone Marrow Transplantation. 25(11). 1121–1127. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact